Clinical and molecular features of X-linked hyper IgM syndrome – An experience from North India
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 195, 59-66
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Medical Research
This publication has 29 references indexed in Scilit:
- Clinical Features and Genetic Analysis of Taiwanese Patients With the Hyper IgM Syndrome PhenotypeThe Pediatric Infectious Disease Journal, 2013
- Primary immunodeficiencies in India: a perspectiveAnnals of the New York Academy of Sciences, 2012
- The Role of CD40/CD40 Ligand Interactions in Bone Marrow GranulopoiesisThe Scientific World Journal, 2011
- Clinical and Laboratory Findings in Hyper-IgM Syndrome with Novel CD40L and AICDA MutationsJournal of Clinical Immunology, 2009
- Hyper‐immunoglobulin M syndrome caused by a mutation in the promotor for CD40LImmunology, 2007
- The structural basis of hyper IgM deficiency – CD40L mutationsProtein Engineering, Design and Selection, 2007
- Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndromeBlood, 2005
- Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.Journal of Clinical Investigation, 1994
- CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM SyndromeScience, 1993
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993